Neurofibromatosis type I and pregnancy: A fatal attraction? Development of malignant schwannoma during pregnancy in a patient with neurofibromatosis type I

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 5, 2003, Pages 530-532

  Posma, E ^a   Aalbers, R ^a   Kurniawan, Y S ^a   Van Essen, A J ^b   Peeters, P M J G ^c   Van Loon, A J ^a  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE;

ABDOMINAL PAIN; ADULT; ANOVULATION; ARTICLE; AUTOPSY; BIRTH WEIGHT; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PAIN; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHILDBIRTH; CHILDHOOD CANCER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LABOR INDUCTION; NEURILEMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVULATION INDUCTION; PHOTOTHERAPY; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PUERPERIUM; RISK FACTOR; THORACOTOMY; THORAX PAIN; THORAX RADIOGRAPHY; TUMOR BIOPSY;

EID: 0038736878     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(02)02649-6     Document Type: Article

References (22)

1. Ruggieri M., Huson S.M. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology. 56:2001;1433-1443.
2. Huson S.M. Neurofibromatosis 1: a clinical and genetic overview. Huson S.M., Hughes R.A.C. The Neurofibromatoses: Pathogenetic and Clinical Overview. 1994;160-203 Chapman & Hall, London.
3. Colman S.D., Rasmussen S.A., Ho V.T., Abernathy C.R., Wallace M.R. Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet. 58:1996;484-490.
4. Friedman J.M. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 89:1999;1-6.
5. Rasmussen S.A., Overman J., Thomson SAet al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer. 28:2000;425-431.
6. John A.M., Ruggieri M., Ferner R., Upadhyaya M. A search for evidence of somatic mutations in the NF1 gene. J Med Genet. 37:2000;44-49.
7. Knudson A.G. Antioncogenes and human cancer. Proc Natl Acad Sci USA. 90:1993;10,914-10,921.
8. Colman S.D., Williams C.A., Wallace M.R. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet. 11:1995;90-92.
9. Serra E., Rosenbaum T., Nadal Met al. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet. 28:2001;294-296.
10. Serra E., Ars E., Ravella Aet al. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Hum Genet. 108:2001;416-429.
11. Sawada S., Florell S., Purandare S.M., Ota M., Stephens K., Viskochil D. Identification of NF1 mutations in both alleles of a neural neurofibroma. Nat Genet. 14:1996;110-112.
12. Woodruff J.M. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet. 89:1999;23-30.
13. King A.A., Debaun M.R., Riccardi V.M., Gutmann D.H. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet. 93:2000;388-392.
14. Evans D.G.R., Baser M.E., McGaughran J., Sharif S., Howard E., Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 39:2002;311-314.
15. Rasmussen S.A., Yang Q., Friedman J.M. Mortality in neurofibromatosis type 1: an analysis using U.S. death certificates. Am J Hum Genet. 68:2001;1110-1118.
16. Zöller M., Rembeck B., Akesson H.O., Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1: a twelve-year follow-up f an epidemiological study in Goteborg, Sweden. Acta Venereol. 75:1995;136-140.
17. Weissman A., Jakobi P., Zaidise I., Drugan A. Neurofibromatosis and pregnancy. An update. J Reprod Med. 38:1993;890-896.
18. Puls L.E., Chandler P.A. Malignant schwannoma in pregnancy. Acta Obstet Gynecol Scand. 70:1991;243-244.
19. Ginsburg D.S., Hernandez E., Johnson J.W. Sarcoma complicating Von Recklinghausen disease in pregnancy. Obstet Gynecol. 58:1981;385-387.
20. Baker V.V., Hatch K.D., Shingleton H.M. Neurofibrosarcoma complicating pregnancy. Gynecol Oncol. 34:1989;237-239.
21. Dugoff L., Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet. 66:1996;7-10.
22. Leslie KK, White M, Sujanski E. Utilization of polymerase chain reaction (PCR) for identification of estrogen receptors in neurofibromas: potential clinical significance [abstract]. National Neurofibromatosis Foundation Annual Clinical Care Conference. New York: National NF Foundation, 1992.